Assertio Holdings, Inc. — Director's Dealing 2020

May 28, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Assertio Holdings, Inc. (ASRT)
CIK: 0001808665
Period of Report: 2020-05-20

Reporting Person: CR Group L.P. (10% Owner)
Reporting Person: CRG Partners III - Parallel Fund (A) L.P. (10% Owner)
Reporting Person: CRG Partners III - Parallel Fund B (Cayman) L.P. (10% Owner)
Reporting Person: CRG Partners III (Cayman) Lev AIV I L.P. (10% Owner)
Reporting Person: CRG Partners III (Cayman) Unlev AIV I L.P. (10% Owner)
Reporting Person: CRG Partners III L.P. (10% Owner)
Reporting Person: Loan Security Holdings I LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11467185	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$0.0004		Common Stock (6091148)		Indirect

Footnotes

F1: Acquired pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 16, 2020, by and among Zyla Life Sciences ("Zyla") and Assertio Therapeutics, Inc., a Delaware corporation, the Issuer, Zebra Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Issuer and Alligator Merger Sub, Inc., a Delaware corporation, whereby each share of Zyla common stock was cancelled and converted into the right to receive 2.5 shares of the Issuer's common stock having a market value of $0.80 per share, the closing price on the day prior to the effective date of the merger, as provided in the Merger Agreement.

F2: The securities are held by Loan Security Holdings I LLC, a wholly owned LLC held by CRG Partners III - Parallel Fund "A" L.P., CRG Partners III - Parallel Fund "B" (Cayman) L.P., CRG Partners III (Cayman) Lev AIV I L.P., CRG Partners III (Cayman) Unlev AIV I L.P., and CRG Partners III L.P. (collectively, the "CRG Entities"). CRG Entities collectively hold all of the issued and outstanding shares of Loan Security Holdings I LLC. CR Group L.P. may be deemed to beneficially own the Shares and the Warrants by virtue of its position as the investment manager for the CRG Entities.

F3: Acquired pursuant to the Merger Agreement in exchange for a warrant to acquire Zyla common stock. The warrants do not have an expiration date.